Covalon Announces Voting Results from Fiscal 2023 Annual Meeting of Shareholders

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the results of the matters voted upon at its Fiscal 2023 Annual Meeting of Shareholders (“AGM”) held March 6, 2024.

Shareholders voted in favour of all items of business and each item of business was approved by the requisite number of votes. The matters included the election of the Board of Directors and the appointment of auditors. The total number of shares represented, either in person or by proxy, totaled 10,665,029 or 43.232%. The voting results are detailed below.

1) The Election of the Board of Directors

Name of Nominee	Votes FOR	%	Votes WITHHELD	%
Brent Ashton	10,481,118	99.811	19,800	0.189
Amir Boloor	10,405,326	99.090	95,592	0.910
Joseph Cordiano	10,363,626	98.693	137,292	1.307
Martin Goldfarb	10,350,326	98.566	150,592	1.434
Samantha Nutt	10,435,784	99.380	65,134	0.620
Abe Schwartz	10,182,126	96.964	318,792	3.036
Ron Smith	10,373,626	98.788	127,292	1.212

2) The Appointment of the Auditor

Votes FOR

%